Investing

Top Analyst Upgrades and Downgrades: BioMarin, Family Dollar, Lululemon, SunTrust and More

It is Monday and 24/7 Wall St. has seen many new analyst research calls that have to be covered. The bull market is on, with stocks having hit new highs on Friday, but investors and traders keep hearing that this is now a stock picker’s market rather than a raging bull market. We review dozens of analyst research reports each morning of the week in order to find new ideas and hidden gems for our readers. Some analyst reports cover stocks to buy, but some of them cover stocks to sell or to avoid.

These are this Monday’s top Wall Street analyst upgrades, downgrades and initiations.

Anixter International Inc. (NYSE: AXE) was downgraded to Neutral from Outperform at R.W. Baird.

Arcos Dorados Holdings Inc. (NYSE: ARCO) was raised to Buy from Underperform and given a $14.16 price target (versus a $9.61 close) at Bank of America Merrill Lynch.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was raised to Outperform from Neutral with a $73 price target (versus a $61.74 close) by Credit Suisse.

ALSO READ: Apple’s New Target Prices After the Split

Capital One Financial Corp. (NYSE: COF) was raised to Buy from Neutral at Nomura Securities.

Dollar General Corp. (NYSE: DG) was raised to Buy from Hold with a $75 price target (versus a $57.98 close) at Jefferies.

ALSO READ: Five Analyst Stocks With Over 100% Implied Upside

Enerplus Corp. (NYSE: ERF) was downgraded to Sector Perform from Outperform at RBC Capital Markets.

Family Dollar Stores Inc. (NYSE: FDO) was raised to Buy from Hold with a $79 price target (versus a $60.53 close) at Jefferies. Sterne Agee maintained a Neutral rating despite the Carl Icahn stake disclosure of 9.4%.

Fifth Third Bancorp (NASDAQ: FITB) was maintained as Buy with a $25 price target (versus a $21.33 close) at Sterne Agee.

L Brands Inc. (NYSE: LB) was raised to Perform from Underperform at Oppenheimer, but the stock was given a $56 price target (versus a $59.50 close).

ALSO READ: 12 Analyst Stocks to Buy Under $10 With Huge Upside

Lululemon Athletica Inc. (NASDAQ: LULU) was maintained as Buy at Canaccord Genuity, with the idea that the stabilization in comparable store sales should form a base.

Novartis A.G. (NYSE: NVS) was raised to Equal Weight from Underweight by Barclays.

Office Depot Inc. (NYSE: ODP) was featured prominently as a Barron’s turnaround stock.

SunTrust Banks Inc. (NYSE: STI) was raised to Outperform from Market Perform and the price target was put at $46 (versus a $39.64 close) by Keefe Bruyette & Woods.

ALSO READ: The Highest Yielding Dividends That Are Safe to Hold

Waste Management Inc. (NYSE: WM) was started as Hold with a mere $47 price target by Deutsche Bank.

Zendesk Inc. (NYSE: ZEN) was started with just a Neutral rating at Goldman Sachs. Canaccord Genuity started coverage with a Buy rating and $19 price target. Pacific Crest started coverage as Outperform and with a $20 price target.

We also have the top earnings previews for this week from RadioShack, Ulta Salon, Lululemon and more.

The #1 Thing to Do Before You Claim Social Security (Sponsor)

Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.

A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.

 

Have questions about retirement or personal finance? Email us at [email protected]!

By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.

By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.